Merge Technologies has released its next-generation MergePort, which integrates information from hospital and radiology information systems with diagnostic imaging technologies. MergePort acts as the interpreter between multiple HIS/RIS and PACS/imaging
Merge Technologies has released its next-generation MergePort, which integrates information from hospital and radiology information systems with diagnostic imaging technologies. MergePort acts as the interpreter between multiple HIS/RIS and PACS/imaging networks, or any other clinical system that utilizes HL7 communications. MergePort receives, converts, and dispatches HL7, DICOM, and custom-formatted messages, securely integrating healthcare applications, imaging modalities, PACS, image archives, and clinical repositories.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Key MRI Findings Predictive of Treatment Response for Unresectable Hepatocellular Carcinoma
July 14th 2025For patients with unresectable hepatocellular carcinoma, a pre-treatment MRI finding of LI-RADS tumor in vein was associated with over an 86 percent lower likelihood of responding to transcatheter arterial chemoembolization (TACE) and targeted immunotherapy.